Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036341 (
schizophrenia
)
60,220
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Olfactory hallucinations
(OHs), so it has been argued, are prognostic of a poorer outcome, are unpleasant, and cannot be well explained within current theoretical accounts of hallucinations. We examined these and related issues by conducting structured interviews with 51 participants who experienced OHs and who were previously diagnosed with
schizophrenia
or schizoaffective disorder. We found no relationship between disease severity measures and type or frequency of OHs. As with prior research, we too noted the predominance of negative OHs, but with many reports of positive OHs, and also found significant relationships between frequency of OHs and severity of tactile hallucinations. We then examined whether odor imagery or involuntary memory might account for the presence of OHs, but these possibilities were not well supported. We then explored, using cluster analysis, whether or not our sample was homogenous. Two clusters were of especial interest; one which may reflect a 'sensory dysfunction group' and one characterized by more severe tactile hallucinations. The presence of tactile hallucinations may suggest a further novel cause of OHs, which we discuss. Our data suggest diverse causes for OHs in
schizophrenia
, none of which are consistent with current models of hallucinations in other modalities.
...
PMID:Olfactory hallucinations in schizophrenia and schizoaffective disorder: a phenomenological survey. 2072 97
Olfactory hallucinations
(OHs) are present in a significant minority of people with
schizophrenia
, yet these symptoms are under-researched and poorly understood. This study aimed to identify the neuropsychological impairments that associate with OHs in
schizophrenia
. Patients with
schizophrenia
or schizoaffective disorder were classified into an OH group and a group with auditory-verbal hallucinations (AVHs) and no lifetime history of OHs. Patients were age- and gender-matched to a healthy control group. All participants were assessed using: a test of odor identification; decision-making and socio-emotional tests of orbitofrontal cortex (OFC) and amygdala function; and a battery of standardized executive tests. Patients, as a whole, performed more poorly than controls on the tests of odor identification, emotion processing and executive function, consistent with previous research. Only two tests of OFC functioning: the Object Alternation Task, taken from Oscar-Berman and Zola-Morgan's (1980a, 1980b) Comparative Neuropsychological Tasks, and a test of "faux pas" understanding discriminated between the OH and AVH patients. Findings provide the first preliminary support for OH-specific neuropsychological impairments associated with OFC dysfunction in
schizophrenia
. (JINS, 2012, 18, 1-10).
...
PMID:Neuropsychological characteristics associated with olfactory hallucinations in schizophrenia. 2261 66
Olfactory hallucinations
(OH) are experienced by a substantial minority of people with
schizophrenia
, often leading to social anxiety, depression and suffering. Yet, despite their prevalence and clinical significance, OH in
schizophrenia
are under-researched and poorly understood, with scarce information about potential treatments. To address this gap in the literature, the author describes a case report of successfully using Cognitive-Behavioral Therapy for psychosis (CBTp) to address OH, related delusions, as well as mood and social functioning difficulties in a male patient with
schizophrenia
. The results provide preliminary support for the feasibility and effectiveness of using CBTp to address OH and related delusions in individuals with
schizophrenia
.
...
PMID:Cognitive-Behavioral Therapy for Olfactory Hallucinations and Associated Delusions: A Case Report. 2705 9